Dr. Mohammad Ahmad Al Efishat, MD

Dr. Al Efishat practices at Regional Eye Surgery Center - Baton Rouge in Baton Rouge, Louisiana.

Dr. Al Efishat's NPI, 1710312400, was assigned on September 12, 2013. Dr. Al Efishat graduated from University of Jordan Faculty of Medicine in 2011. Dr. Al Efishat's Louisiana license number on file is 329841.

Dr. Al Efishat's primary practice is Regional Eye Surgery Center - Baton Rouge, at 7777 Hennessey Blvd, Suite 5000, Baton Rouge, LA 70808. The practice phone is (225) 214-6688.

Dr. Al Efishat's primary practice is Regional Eye Surgery Center - Baton Rouge in Baton Rouge, Louisiana. Dr. Al Efishat is also affiliated with Our Lady of the Lake Regional Medical Center. The medical group on file is Our Lady of the Lake Physician Group. Dmand AI also links Dr. Al Efishat to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al Efishat practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Al Efishat's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Al Efishat is board certified in complex general surgical oncology by the American Board of Surgery. Dmand AI has Dr. Al Efishat's licenses on file in 2 states: Louisiana and Maryland.

Dmand AI lists abdominal adhesion surgery, acute gallbladder or bile duct inflammation, appendectomy, cancerous skin growth removal, colon removal, esophagus, stomach, or upper small intestine surgery, gallbladder removal and gastrointestinal obstruction among the conditions Dr. Al Efishat treats.

CMS data shows 106 Medicare services from Dr. Al Efishat across 5 procedure codes in 2024, for 96 Medicare patients. Medicare paid $7,727 for them.

CMS counts 96 Medicare patients who saw Dr. Al Efishat in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al Efishat's median patient age at 64, with 56% women.

In 2024, Dr. Al Efishat wrote 52 Medicare Part D claims for 22 patients. 81% of them were for generic drugs.

Dr. Al Efishat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Al Efishat as offering telehealth. CMS counts 12 procedures of removal of tissue by Dr. Al Efishat, more than 63% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Al Efishat, published from 2015 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal and Pancreas. Dr. Al Efishat's most frequent co-authors are Christopher Wolfgang, MD, PhD, Matthew Weiss, MD and Peter J. Allen, MD.

CMS Open Payments shows 100 general payments to Dr. Al Efishat from 32 drug and device companies from 2022 to 2025. Education make up the largest share, 61% of the total. Intuitive Surgical, Inc. paid the most, $17,143.

Dr. Al Efishat graduated from University of Jordan Faculty of Medicine in 2011.

Dr. Al Efishat is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.